LifeSciVC

AUGUST 21, 2024

Clinical Trials Are your clinical trials on track? Companies fortunate enough to have reached the clinical stage are asking this question. What has the impact of summer been on recruiting efforts and the ability to manage clinical trial participants? Or maybe you are nearing the clinic.

Clinical Trials 72

Clinical Trials Trials Disease Treatment 72

The Pharma Data

JANUARY 10, 2021

Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than 100 product candidates, of which 27 are currently in clinical development. In July 2020, the U.S. subsidiary MorphoSys US Inc., has more than 600 employees.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Supply Trials 52

The Pharma Data

NOVEMBER 22, 2020

. “In collaboration with our partner, Novartis, our team continues to move at extraordinary speed from idea to bench to clinical trials, driven by a common desire to help patients against this devastating disease and help bring the world back closer to normalcy.” million doses of MP0420, if it is approved in Switzerland.

Trials 40

Trials Clinical Trials Licensing Licensing 40

Alta Sciences

DECEMBER 14, 2023

Clinical Supply Manufacturing Integration with our manufacturing team, ensuring flexibility and adaptability to meet the evolving needs of your studies throughout your drug development program or study. We also provide analytical testing, ICH stability storage and testing, as well as finished product and release testing.

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

The Pharma Data

AUGUST 15, 2021

VTX-801 is a novel investigational gene therapy to be evaluated in a Phase 1/2 clinical trial to determine the safety, tolerability, and pharmacological activity of a single intravenous infusion in adult patients with Wilson Disease. Pfizer is collaborating with Vivet on the clinical supply of VTX-801 for the Phase 1/2 clinical trial.

Disease 52

Disease FDA Treatment Clinical Trials 52

The Pharma Data

NOVEMBER 18, 2020

. Approval of amendments to PARADIGME protocol is proceeding as planned and completed in the best-recruiting countries Designed to enlarge the eligible patient population and increase the rate of enrolment into the trial. 59 patients enrolled as of 18 November 2020. Financial Highlights.

Trials 40

Trials Clinical Supply Production Therapies 40

The Pharma Data

DECEMBER 4, 2021

company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.

Drug Development 52

Drug Development Small Molecule Synthetic Chemistry Drugs 52

The Premier Consulting Blog

OCTOBER 26, 2022

The varying groups that generate or summarize the information that comprises the MPD over the course of development are called the sending unit , and the group that utilizes the information to manufacture the drug substance or drug product is call the receiving unit.

Production 40

Production Assay Development Clinical Supply Engineering 40

The Pharma Data

OCTOBER 27, 2020

Molecular Partners, a global leader in the development of DARPin® therapeutics, will be responsible for the conduct of phase 1 & 2 trials that may lead to emergency use approval; Novartis will be responsible for further development, manufacturing, distribution and commercialization. About Molecular Partners AG.

Therapies 40

Therapies Virus Treatment Clinical Trials 40

The Pharma Data

JANUARY 24, 2021

Management of the Company believe that the proposed acquisition will strengthen PharmaDrug’s product pipeline, intellectual property portfolio and pharmaceutical development expertise. Cepharanthine is a natural product and an approved drug used for more than 70 years in Japan to treat a variety of acute and chronic diseases.

FDA 52

FDA Drugs Clinical Development Disease 52

PPD

FEBRUARY 3, 2025

In todays clinical research landscape, it is both essential and challenging to accelerate clinical trials. Delays in clinical trials can have significant financial consequences for sponsors. The challenges are compounded by increasing trial complexities.

Clinical Trials 52

Clinical Trials Trials Clinical Supply Drug Development 52